[{"address1": "Hohenrainstrasse 24", "city": "Pratteln", "zip": "4133", "country": "Switzerland", "phone": "41 61 906 89 50", "fax": "41 61 906 89 51", "website": "https://www.santhera.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Dr. Thomas  Meier Ph.D.", "age": 61, "title": "Founder & Chairman", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 118800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dario  Eklund", "age": 55, "title": "Chief Executive Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1190735, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew P. Smith CGMA, FCMA", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Oliver  Strub", "age": 60, "title": "Head of Compliance", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. G\u00fcnther  Metz Ph.D.", "age": 65, "title": "Head Business Development", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shabir  Hasham M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Schrader", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eva  Kalias", "title": "Head of Investor Relations & Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oliver P. Kronenberg", "title": "Chief Legal Officer & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neville  Kodkani M.D.", "title": "Head of Global Marketing & Partner Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 11.7, "open": 11.7, "dayLow": 11.7, "dayHigh": 11.7, "regularMarketPreviousClose": 11.7, "regularMarketOpen": 11.7, "regularMarketDayLow": 11.7, "regularMarketDayHigh": 11.7, "beta": 0.115, "volume": 59, "regularMarketVolume": 59, "averageVolume": 9, "marketCap": 132440488, "fiftyTwoWeekLow": 0.68, "fiftyTwoWeekHigh": 13.35, "priceToSalesTrailing12Months": 1.2806823, "fiftyDayAverage": 11.7, "twoHundredDayAverage": 11.7915, "currency": "USD", "enterpriseValue": 123566944, "profitMargins": 0.52973, "floatShares": 8368729, "sharesOutstanding": 11319700, "heldPercentInsiders": 0.21361999, "heldPercentInstitutions": 0.03257, "bookValue": 5.298, "priceToBook": 2.2083805, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": 54782000, "trailingEps": -9.5, "enterpriseToRevenue": 1.195, "enterpriseToEbitda": 2.298, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "SPHDF", "underlyingSymbol": "SPHDF", "shortName": "SANTHERA PHARMACEUTICALS HOLDIN", "longName": "Santhera Pharmaceuticals Holding AG", "firstTradeDateEpochUtc": 1404221400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "37302cd3-05a1-3fa1-890b-ea0479b9691a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 11.7, "recommendationKey": "none", "totalCash": 30370000, "totalCashPerShare": 2.684, "ebitda": 53762000, "totalDebt": 21549000, "quickRatio": 0.734, "currentRatio": 0.782, "totalRevenue": 103414000, "debtToEquity": 35.949, "revenuePerShare": 9.776, "returnOnAssets": 0.3689, "returnOnEquity": 6.7395, "freeCashflow": -2492625, "operatingCashflow": 47271000, "revenueGrowth": 80.337, "grossMargins": 0.96872, "ebitdaMargins": 0.51987, "operatingMargins": 0.71843004, "financialCurrency": "CHF", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]